Titan Biotech Limited (BOM:524717)
India
· Delayed Price · Currency is INR 422.85
-3.20 (-0.75%)
At close: Jun 17, 2025
Titan Biotech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 16, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 3,494 | 3,484 | 4,365 | 1,627 | 2,166 | 1,533 | Upgrade
|
| Market Cap Growth | -20.19% | -20.19% | 168.33% | -24.88% | 41.23% | 335.05% | Upgrade
|
| Enterprise Value | 3,467 | 3,409 | 4,405 | 1,665 | 2,381 | 1,592 | Upgrade
|
| Last Close Price | 422.85 | 421.55 | 526.59 | 195.23 | 258.52 | 182.26 | Upgrade
|
| PE Ratio | 16.23 | 16.18 | 17.56 | 6.55 | 9.99 | 5.06 | Upgrade
|
| PS Ratio | 2.23 | 2.23 | 2.66 | 1.13 | 1.75 | 1.08 | Upgrade
|
| PB Ratio | 2.28 | 2.27 | 3.27 | 1.48 | 2.51 | 2.12 | Upgrade
|
| P/TBV Ratio | 2.28 | 2.27 | 3.27 | 1.48 | 2.51 | 2.23 | Upgrade
|
| P/FCF Ratio | 32.49 | 32.39 | 262.72 | 19.26 | 13.77 | 9.54 | Upgrade
|
| P/OCF Ratio | 17.36 | 17.31 | 20.64 | 7.68 | 9.82 | 8.04 | Upgrade
|
| EV/Sales Ratio | 2.22 | 2.18 | 2.69 | 1.16 | 1.93 | 1.12 | Upgrade
|
| EV/EBITDA Ratio | 12.08 | 13.41 | 13.09 | 5.76 | 7.74 | 3.46 | Upgrade
|
| EV/EBIT Ratio | 14.14 | 16.04 | 14.30 | 6.21 | 8.26 | 3.60 | Upgrade
|
| EV/FCF Ratio | 32.23 | 31.70 | 265.13 | 19.72 | 15.14 | 9.91 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.06 | 0.08 | 0.10 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | 0.11 | 0.11 | 0.24 | 0.29 | 0.29 | 0.34 | Upgrade
|
| Debt / FCF Ratio | 0.26 | 0.26 | 5.00 | 1.01 | 0.57 | 1.00 | Upgrade
|
| Asset Turnover | 0.95 | 0.95 | 1.13 | 1.19 | 1.18 | 1.61 | Upgrade
|
| Inventory Turnover | 1.51 | 1.51 | 1.88 | 2.01 | 1.78 | 2.13 | Upgrade
|
| Quick Ratio | 1.37 | 1.37 | 1.12 | 1.27 | 1.37 | 1.22 | Upgrade
|
| Current Ratio | 4.46 | 4.46 | 3.77 | 3.36 | 3.76 | 3.05 | Upgrade
|
| Return on Equity (ROE) | 15.01% | 15.01% | 20.42% | 25.33% | 27.32% | 55.61% | Upgrade
|
| Return on Assets (ROA) | 8.02% | 8.02% | 13.23% | 13.81% | 17.25% | 31.25% | Upgrade
|
| Return on Capital (ROIC) | 8.92% | 8.92% | 14.80% | 15.69% | 19.61% | 35.90% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.50% | 13.50% | 22.40% | 23.50% | 31.60% | 54.30% | Upgrade
|
| Earnings Yield | 6.16% | 6.18% | 5.69% | 15.27% | 10.01% | 19.78% | Upgrade
|
| FCF Yield | 3.08% | 3.09% | 0.38% | 5.19% | 7.26% | 10.48% | Upgrade
|
| Dividend Yield | 0.47% | 0.47% | 0.38% | 0.92% | 0.58% | 0.82% | Upgrade
|
| Payout Ratio | 7.68% | 7.68% | 5.99% | 4.99% | 5.72% | 2.72% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | 0.02% | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.49% | 0.49% | 0.38% | 0.92% | 0.58% | 0.82% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.